221 related articles for article (PubMed ID: 26983574)
1. Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
Ayala-Ortega E; Arzate-Mejía R; Pérez-Molina R; González-Buendía E; Meier K; Guerrero G; Recillas-Targa F
BMC Cancer; 2016 Mar; 16():226. PubMed ID: 26983574
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
3. Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA
BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129
[TBL] [Abstract][Full Text] [Related]
4. MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.
Lakomy R; Sana J; Hankeova S; Fadrus P; Kren L; Lzicarova E; Svoboda M; Dolezelova H; Smrcka M; Vyzula R; Michalek J; Hajduch M; Slaby O
Cancer Sci; 2011 Dec; 102(12):2186-90. PubMed ID: 21895872
[TBL] [Abstract][Full Text] [Related]
5. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Devor EJ; Miecznikowski J; Schickling BM; Gonzalez-Bosquet J; Lankes HA; Thaker P; Argenta PA; Pearl ML; Zweizig SL; Mannel RS; Brown A; Ramirez NC; Ioffe OB; Park KJ; Creasman WT; Birrer MJ; Mutch D; Leslie KK
Gynecol Oncol; 2017 Dec; 147(3):648-653. PubMed ID: 28969912
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma.
Tivnan A; Zhao J; Johns TG; Day BW; Stringer BW; Boyd AW; Tiwari S; Giles KM; Teo C; McDonald KL
Tumour Biol; 2014 Feb; 35(2):1459-65. PubMed ID: 24068568
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Modification of MicroRNA-205 and its Association with Glioblastoma Multiform.
Ghasemi A; Fallah S
Clin Lab; 2017 Jul; 63(7):1079-1088. PubMed ID: 28792704
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.
Soto-Reyes E; Recillas-Targa F
Oncogene; 2010 Apr; 29(15):2217-27. PubMed ID: 20101205
[TBL] [Abstract][Full Text] [Related]
11. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms.
Haag T; Richter AM; Schneider MB; Jiménez AP; Dammann RH
BMC Cancer; 2016 Feb; 16():49. PubMed ID: 26833217
[TBL] [Abstract][Full Text] [Related]
12. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.
Kang JY; Song SH; Yun J; Jeon MS; Kim HP; Han SW; Kim TY
Oncogene; 2015 Nov; 34(45):5677-84. PubMed ID: 25703332
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.
Victoria-Acosta G; Vazquez-Santillan K; Jimenez-Hernandez L; Muñoz-Galindo L; Maldonado V; Martinez-Ruiz GU; Melendez-Zajgla J
Sci Rep; 2015 Oct; 5():14838. PubMed ID: 26443201
[TBL] [Abstract][Full Text] [Related]
14. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
15. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway.
He X; Liu Z; Peng Y; Yu C
Biochem Biophys Res Commun; 2016 Jan; 469(4):1041-8. PubMed ID: 26682928
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ
PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834
[TBL] [Abstract][Full Text] [Related]
18. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
[TBL] [Abstract][Full Text] [Related]
19. Extensive modulation of a set of microRNAs in primary glioblastoma.
Ciafrè SA; Galardi S; Mangiola A; Ferracin M; Liu CG; Sabatino G; Negrini M; Maira G; Croce CM; Farace MG
Biochem Biophys Res Commun; 2005 Sep; 334(4):1351-8. PubMed ID: 16039986
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
